Wellgistics Health Inc. (NASDAQ: WGRX) has launched a new payment system using the XRP Ledger for independent pharmacies across the United States.
The company said the program, which was announced this week, gives pharmacies the ability to pay for drug inventory instantly while keeping costs transparent and transactions secure. It marks one of the first healthcare deployments of Ripple Labs’ blockchain system at a large scale, targeting thousands of pharmacies nationwide.
Benefits: Instant Payment with Lower Fees
The system is connected with RxERP, a pharmaceutical e-commerce and enterprise platform that manages orders payment and reporting for users. Pharmacies can now sign up for the beta version of the program at the company’s website.
According to Wellgistics, the benefits include instant settlement in seconds, lower fees than credit cards, real-time payment tracking, and direct transfers without middlemen.
“We’ve been impressed with the response so far,” said Brian Norton, CEO of Wellgistics Health. “Independent pharmacy owners are far more forward-thinking than many realize. They see the power of blockchain and understand how transformative this will be as it scales across the industry.” The company currently serves more than 6,500 independent pharmacies and over 200 manufacturers, giving the rollout a wide potential reach.
The platform runs on the XRP Ledger, also known as XRPL, which is an open-source blockchain developed by Ripple Labs. Wellgistics has not said if pharmacies must hold XRP directly or use conversions, but stressed that the program meets compliance rules, including HIPAA and anti-money laundering requirements.
What’s Next for Wellgistics
The company also plans to expand the system further. Manufacturers will be added to the network next, and Wellgistics is preparing direct-to-patient programs that allow drugmakers to ship medications directly to homes under physician supervision.
Meanwhile, Wellgistics previously announced on May 8 that it would also adopt XRP as a treasury reserve asset. That plan is supported by a $50 million equity line of credit to build on-demand financial infrastructure across its healthcare network.
Founded in 2016 and spun off as a public company in February 2025, Wellgistics shares have dropped more than 80% since listing. The stock closed Friday at $0.6211, down 7% from the previous day.
